Edifice Health provides the Inflammatory Age® test, a biomarker composite scoring system developed from a decade-long NIH-funded study, to measure and monitor systemic chronic inflammation. This technology enables healthcare providers to identify and manage chronic inflammation, which is linked to age-related diseases and overall health deterioration.
Funding
$15.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
LBFounders
Product
Problem
Systemic chronic inflammation is a root cause of many age-related diseases and overall health deterioration, but it is difficult to measure and monitor effectively with traditional methods. This lack of precise monitoring hinders proactive management and early detection of inflammation-related health issues.
Solution
Edifice Health offers the Inflammatory Age® test, a biomarker composite scoring system derived from a decade-long NIH-funded study, to quantify and track systemic chronic inflammation. Using advanced 'omics' platforms and artificial intelligence, the test provides insights into an individual's inflammatory and immune health. The Inflammatory Age® metric predicts multi-morbidity, immune function, and cumulative physiological damage, offering previously unattainable insights into biological health. By partnering with clinics and physicians, Edifice Health aims to facilitate early detection and prevention of disease through proactive management of chronic inflammation.
Target Audience
The primary target audience includes healthcare providers focusing on early detection and prevention of disease, as well as individuals interested in proactively managing their inflammatory health for better overall health and longevity.
Features
- Biomarker composite scoring system for measuring systemic chronic inflammation
- Derived from a 10-year NIH-funded longitudinal research study (Stanford 1,000 Immunomes Project)
- Utilizes state-of-the-art 'omics' platforms and advanced artificial intelligence methods
- Provides an Inflammatory Age® metric that predicts multi-morbidity, immune function, and cumulative physiological damage